Jennifer M. Mongiovi

observational 2026

Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive use

British journal of cancer ·doi:10.1038/s41416-026-03508-9

BACKGROUND: Non-hormonal intrauterine devices (IUDs) create an inflammatory uterine environment while oral contraceptives (OC) suppress ovulation and have different associations with ovarian cancer risk. We have evaluated the associations o…

observational 2025

Associations between common contraceptive use and circulating inflammatory biomarkers

American Journal of Epidemiology ·doi:10.1093/aje/kwae135

Ovarian cancer incidence has declined in recent decades, due in part to oral contraceptive (OC) use and tubal ligation. However, intrauterine device (IUD) use has increasingly replaced OC use. As ovarian cancer is an inflammation-related di…

observational 2025

Associations between Parity, History of Breastfeeding, and T-cell Profile of Ovarian Tumors

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.epi-24-1414

BACKGROUND: Parity and breastfeeding are associated with systemic changes in maternal inflammation and reduced risk of ovarian cancer, but little is known about their impact on the ovarian tumor immune microenvironment. METHODS: We evaluat…

observational 2024

Differences in characteristics and use of complementary and alternative methods for coping with endometriosis-associated acyclic pelvic pain across adolescence and adulthood

Frontiers in reproductive health ·doi:10.3389/frph.2023.1306380

INTRODUCTION: Over four million women in the US alone have been diagnosed with endometriosis. For those living with this disease, surgery and hormonal treatment reduce associated pelvic pain in some, while others continue to experience life…